Abstract
Rationale The major human genes regulating M. tuberculosis (Mtb)-induced immune responses and tuberculosis (TB) susceptibility are poorly understood. Although IL-12 and IL-10 are critical for TB pathogenesis, the genetic factors that regulate their expression are unknown. CNBP, REL, and BHLHE40 are master regulators of IL-12 and IL-10 signaling.
Objectives To determine whether common human genetic variation in CNBP, REL and BHLHE40 is associated with IL-12 and IL-10 expression, adaptive immune responses to mycobacteria, and susceptibility to TB.
Methods and Main Measurements We characterized the association between common variants in CNBP, REL, and BHLHE40 and innate immune responses in dendritic cells and monocyte-derived macrophages (MDM), BCG-specific T cell responses, and susceptibility to pediatric and adult TB.
Results SNP BHLHE40 rs4496464 was associated with increased BHLHE40 expression in MDMs and increased IL-10 from both peripheral blood dendritic cells and MDMs after LPS and TB whole cell lysate stimulation. SNP BHLHE40 rs11130215, in linkage disequilibrium with rs4496464, was associated with increased BCG-specific IL2+CD4+ T cell responses and decreased risk for pediatric TB in South Africa. SNPs REL rs842634 and CNBP rs11709852 were associated with increased IL-12 production from dendritic cells, and SNP REL rs842618, in linkage disequilibrium with rs842634, was associated with increased risk for TB meningitis.
Conclusions Genetic variation in CNBP, REL, and BHLHE40 is associated with IL-12 and IL-10 cytokine response and TB clinical outcomes. Common human genetic regulation of well-defined intermediate cellular traits provides insights into mechanisms of TB pathogenesis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by funding from the following NIH grants: R01 AI136921 to JAS; P01 AI132130 to CMS, TRH, JAS, SJD, TJS; K24 AI137310 to TRH; AI067497 to KAF. No authors received any other payment or services from a third party for any aspect of the submitted work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval for human study protocols was obtained from the institutional review boards at local sites and at the University of Washington School of Medicine (Seattle, WA). The South African study included written informed consent from the parent or legal guardian of the participant and approval by the University of Cape Town Research Ethics Committee. Written informed consent was received from all participants before inclusion in the study. For genetic studies in Vietnam, approval for human study protocols was obtained from the human subjects review boards at the University of Washington School of Medicine, the Hospital for Tropical Diseases, Pham Ngoc Thach Hospital, Hung Vuong Hospital, and the Oxford Tropical Research Ethics Committee. Written informed consent was obtained from patients or their relatives if the patient could not provide consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Grant Support: R01 AI136921 to JAS; P01 AI132130 to CMS, TRH, JAS, SJD, TJS; K24 AI137310 to TRH; AI067497 to KAF.
Descriptor Number: 10.6 Host Defenses to Microbial Pathogens
This article has an online data supplement, which is accessible from this issue’s table of content online at www.atsjournals.org.
Data Availability
All data collected in this manuscript is publicly available upon request to the corresponding author.
